Invesco Pharmaceuticals ETF (PJP) is a Invesco ETF with a 0.58% expense ratio, 31 holdings and $555MM in net assets. Largest sector: Healthcare (100%).
Fee
0.58%
expense ratio
Net assets
$555MM
Launched
Jun 23, 2005
Holdings
31
as of Oct 24, 2026
Top 10 weight
51.5%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 1.06%
as of Oct 22, 2026
Benchmark
Dynamic Pharmaceutical Intellidex Index
PJP's holdings are as of Oct 24, 2026.
Healthcare
100.0%
1
ABBV
ABBVIE
6.00%
2
PFE
PFIZER
5.83%
3
GILD
GILEAD SCIENCES
5.82%
4
LLY
ELI LILLY
5.72%
5
AMGN
AMGEN
5.49%
6
JNJ
JOHNSON + JOHNSON
5.36%
7
MRK
MERCK
5.15%
8
ABT
ABBOTT LABORATORIES
4.97%
9
AMRX
Amneal Pharmaceuticals
3.60%
10
BIIB
BIOGEN
3.59%
11
UTHR
United Therapeutics
3.58%
12
PRGO
Perrigo
3.48%
13
LGND
Ligand Pharmaceuticals
3.41%
14
VTRS
VIATRIS
3.40%
15
INVA
Innoviva
3.08%
16
REGN
REGENERON PHARMACEUTICALS
3.05%
17
ANIP
ANI Pharmaceuticals
3.03%
18
TARS
Tarsus Pharmaceuticals
3.02%
19
PBH
Prestige Consumer Healthcare
2.94%
20
HRMY
Harmony Biosciences Holdings
2.93%
21
BMY
BRISTOL-MYERS SQUIBB
2.89%
22
COLL
Collegium Pharmaceutical
2.64%
23
JAZZ
Jazz Pharmaceuticals
2.60%
24
TVTX
Travere Therapeutics
2.36%
25
CORT
Corcept Therapeutics
2.20%
1–25 of 31
Funds listed by how much of their largest holdings they share with PJP — not a ranking.
Data from Invesco; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.